Organism | Feature Type | Feature ID | Info | Relationship | Display | Orthologous Group | Coexpression Group |
---|---|---|---|---|---|---|---|
Vitis vinifera | polypeptide | GSVIVT01003976001.Genoscope12X | GSVIVT01003976001 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 9) | OG0000506 | |
Vitis vinifera | polypeptide | GSVIVT01004747001.Genoscope12X | GSVIVT01004747001 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 3) | OG0000506 | |
Vitis vinifera | polypeptide | GSVIVT01007562001.Genoscope12X | GSVIVT01007562001 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 9) | OG0000506 | |
Vitis vinifera | polypeptide | GSVIVT01014701001.Genoscope12X | GSVIVT01014701001 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 9) | OG0000506 | |
Vitis vinifera | polypeptide | GSVIVT01020994001.Genoscope12X | GSVIVT01020994001 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 3) | OG0000506 | |
Vitis vinifera | polypeptide | GSVIVT01030113001.Genoscope12X | GSVIVT01030113001 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 9) | OG0000506 | |
Glycine max | polypeptide | Glyma.02G301100.1.Wm82.a2.v1 | Glyma.02G301100.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.02G308200.1.Wm82.a2.v1 | Glyma.02G308200.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.03G084000.1.Wm82.a2.v1 | Glyma.03G084000.1 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) | OG0000506 | |
Glycine max | polypeptide | Glyma.05G044400.1.Wm82.a2.v1 | Glyma.05G044400.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.06G248300.1.Wm82.a2.v1 | Glyma.06G248300.1 | mRNA | PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) | OG0000506 | |
Glycine max | polypeptide | Glyma.08G330400.1.Wm82.a2.v1 | Glyma.08G330400.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.08G349500.1.Wm82.a2.v1 | Glyma.08G349500.1 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) | OG0000506 | |
Glycine max | polypeptide | Glyma.08G349500.2.Wm82.a2.v1 | Glyma.08G349500.2 | mRNA | OG0000506 | ||
Glycine max | polypeptide | Glyma.08G349500.3.Wm82.a2.v1 | Glyma.08G349500.3 | mRNA | OG0000506 | ||
Glycine max | polypeptide | Glyma.10G110600.1.Wm82.a2.v1 | Glyma.10G110600.1 | mRNA | PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) | OG0000506 | |
Glycine max | polypeptide | Glyma.11G245900.1.Wm82.a2.v1 | Glyma.11G245900.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.12G102200.1.Wm82.a2.v1 | Glyma.12G102200.1 | mRNA | PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) | OG0000506 | |
Glycine max | polypeptide | Glyma.14G013000.1.Wm82.a2.v1 | Glyma.14G013000.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.16G090700.1.Wm82.a2.v1 | Glyma.16G090700.1 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) | OG0000506 | |
Glycine max | polypeptide | Glyma.17G126900.1.Wm82.a2.v1 | Glyma.17G126900.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.17G126900.2.Wm82.a2.v1 | Glyma.17G126900.2 | mRNA | OG0000506 | ||
Glycine max | polypeptide | Glyma.17G184500.1.Wm82.a2.v1 | Glyma.17G184500.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.17G193000.1.Wm82.a2.v1 | Glyma.17G193000.1 | mRNA | PTHR33159:SF3 - RPM1-INTERACTING PROTEIN 4-LIKE PROTEIN (1 of 4) | OG0000506 | |
Glycine max | polypeptide | Glyma.17G193500.1.Wm82.a2.v1 | Glyma.17G193500.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.18G011300.1.Wm82.a2.v1 | Glyma.18G011300.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.18G011300.2.Wm82.a2.v1 | Glyma.18G011300.2 | mRNA | OG0000506 | ||
Glycine max | polypeptide | Glyma.18G075900.1.Wm82.a2.v1 | Glyma.18G075900.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 25) | OG0000506 | |
Glycine max | polypeptide | Glyma.18G166800.1.Wm82.a2.v1 | Glyma.18G166800.1 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 5) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.001G232400.1.v2.1 | Gorai.001G232400.1 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 2) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.002G101100.1.v2.1 | Gorai.002G101100.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.002G101100.2.v2.1 | Gorai.002G101100.2 | mRNA | OG0000506 | ||
Gossypium raimondii | polypeptide | Gorai.003G003800.1.v2.1 | Gorai.003G003800.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.004G226600.1.v2.1 | Gorai.004G226600.1 | mRNA | K13456 - RPM1-interacting protein 4 (RIN4) (1 of 2) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.004G226600.2.v2.1 | Gorai.004G226600.2 | mRNA | OG0000506 | ||
Gossypium raimondii | polypeptide | Gorai.004G226600.3.v2.1 | Gorai.004G226600.3 | mRNA | OG0000506 | ||
Gossypium raimondii | polypeptide | Gorai.005G173700.1.v2.1 | Gorai.005G173700.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.005G173700.2.v2.1 | Gorai.005G173700.2 | mRNA | OG0000506 | ||
Gossypium raimondii | polypeptide | Gorai.006G270200.1.v2.1 | Gorai.006G270200.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.007G165500.1.v2.1 | Gorai.007G165500.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.007G310200.1.v2.1 | Gorai.007G310200.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.008G204500.1.v2.1 | Gorai.008G204500.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.008G204500.2.v2.1 | Gorai.008G204500.2 | mRNA | OG0000506 | ||
Gossypium raimondii | polypeptide | Gorai.008G204500.3.v2.1 | Gorai.008G204500.3 | mRNA | OG0000506 | ||
Gossypium raimondii | polypeptide | Gorai.009G451800.1.v2.1 | Gorai.009G451800.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.009G451800.2.v2.1 | Gorai.009G451800.2 | mRNA | OG0000506 | ||
Gossypium raimondii | polypeptide | Gorai.010G250900.1.v2.1 | Gorai.010G250900.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Gossypium raimondii | polypeptide | Gorai.013G151900.1.v2.1 | Gorai.013G151900.1 | mRNA | PF05627 - Cleavage site for pathogenic type III effector avirulence factor Avr (AvrRpt-cleavage) (1 of 17) | OG0000506 | |
Boea hygrometrica | polypeptide | KZV16334.1 | mRNA | hypothetical protein | OG0000506 | ||
Boea hygrometrica | polypeptide | KZV17686.1 | mRNA | hypothetical protein | OG0000506 |